Роль неоадъювантной гормонотерапии в лечении рака молочной железы: что мы знаем на данный момент?В. В. Воротников,
V. V. Vorotnikov,
Р. А. Пахомова,
R. A. Pakhomova,
А. В. Сойнов,
A. V. Soinov,
А. С. Гунина,
A. S. Gunina,
И. В. Копытич,
I. V. Kopytich,
М. Г. Цой,
M. G. Tsoi,
С. А. Абдугаффоров,
S. A. Abdugafforov (Креативная хирургия и онкология, №3, 2022) Preoperative Hormone Therapy in the Treatment of
Breast Cancer: What Do We Know So Far?
Mingazheva, E.T.,
Prokofyeva, D.S.,
Valova, Ya.V.,
Andreeva, E.A.,
Nurgalieva, A.Kh.,
Valiev, R.R.,
Ekomasova, N.V.,
Faishanova, R.R.,
Romanova, A.R.,
Khusnutdinova, E.K. (2022) involved in the
disease. As a result of previous exome sequencing of DNA samples from
breast cancer Germany
Dzhaubermezov, M.,
Ekomasova, N.,
Mustafin, R.,
Gabidullina, L.,
Galimova, Y.,
Nurgalieva, A.,
Valova, Y.,
Prokofyeva, D.,
Khusnutdinova, E. (2022) , colorectal
cancer,
breast cancer, and cervical
cancer. Genotyping was
performed on 540 supposedly healthy
Sufianova, Galina,
Sufianova, Galina,
Beylerli, Ozal,
Wu, Jianing,
Shumadalova, Alina,
Sufianov, Albert,
Chen, Xin,
Zhao, Shiguang (2022) of
cancer. The onset and progression of tumors may be related directly to oxidative stress, or inflammation